Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Hirotoshi, Sakaguchi"'
Autor:
Norihito Ikenobe, Kentaro Fujimori, Yoshihiro Gocho, Shota Myojin, Masaki Yamada, Kenichi Imadome, Mikiko Miyasaka, Osamu Miyazaki, Akihiro Yoneda, Shotaro Matsumoto, Satoshi Nakagawa, Takao Deguchi, Akihiro Iguchi, Daisuke Tomizawa, Chikara Ogimi, Kimikazu Matsumoto, Hirotoshi Sakaguchi
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 1072-1075 (2024)
Abstract Urgent haploidentical haematopoietic cell transplantation may be considered in cases of severe aplastic anaemia (SAA) without a human leukocyte antigen‐matched donor and suffering from severe infection. However, deciding on allogeneic tran
Externí odkaz:
https://doaj.org/article/168925a4cbe544b789e1c25cf714ec34
Autor:
Hisashi Ishida, Yuta Kawahara, Daisuke Tomizawa, Yasuhiro Okamoto, Asahito Hama, Yuko Cho, Katsuyoshi Koh, Yuhki Koga, Nao Yoshida, Maho Sato, Kiminori Terui, Naoyuki Miyagawa, Akihiro Watanabe, Junko Takita, Ryoji Kobayashi, Masaki Yamamoto, Kenichiro Watanabe, Keiko Okada, Koji Kato, Kimikazu Matsumoto, Moeko Hino, Ken Tabuchi, Hirotoshi Sakaguchi
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract Although killer Ig-like receptor ligands (KIR-L) mismatch has been associated with alloreactive natural killer cell activity and potent graft-versus-leukemia (GVL) effect among adults with acute myeloid leukemia (AML), its role among childre
Externí odkaz:
https://doaj.org/article/4ed23d4696ce46eb92bcc28379e65728
Autor:
Hisashi Ishida, Shin-ichi Tsujimoto, Daisuke Hasegawa, Hirotoshi Sakaguchi, Shohei Yamamoto, Masakatsu Yanagimachi, Katsuyoshi Koh, Akihiro Watanabe, Asahito Hama, Yuko Cho, Kenichiro Watanabe, Maiko Noguchi, Masanobu Takeuchi, Junko Takita, Kana Washio, Keisuke Kato, Takashi Koike, Yoshiko Hashii, Ken Tabuchi, Moeko Hino, Yoshiko Atsuta, Yasuhiro Okamoto
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/fdbfc4409600419fb649625f0f484d67
Autor:
Yoshiyuki Takahashi, Hisashi Noma, Akiko Saito, Keizo Horibe, Hirotoshi Sakaguchi, Katsustugu Umeda, Itaru Kato, Kimiyoshi Sakaguchi, Hidefumi Hiramatsu, Hiroyuki Ishida, Hiromasa Yabe, Hiroaki Goto, Yuta Kawahara, Yuka Iijima Yamashita, Masashi Sanada, Takao Deguchi, Takashi Taga, Souichi Adachi
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Relapsed and refractory B-cell acute lymphoblastic leukaemia (R/R-B-ALL) is linked to a significant relapse rate after allogeneic haematopoietic cell transplantation (allo-HCT) in children, adolescents and young adults (CAYA). No standar
Externí odkaz:
https://doaj.org/article/4e2a3190c22c4e4381335bdb12f4486c
Autor:
Ryo Maemura, Manabu Wakamatsu, Kana Matsumoto, Hirotoshi Sakaguchi, Nao Yoshida, Asahito Hama, Taro Yoshida, Shunsuke Miwata, Hironobu Kitazawa, Kotaro Narita, Shinsuke Kataoka, Daisuke Ichikawa, Motoharu Hamada, Rieko Taniguchi, Kyogo Suzuki, Nozomu Kawashima, Eri Nishikawa, Atsushi Narita, Yusuke Okuno, Nobuhiro Nishio, Koji Kato, Seiji Kojima, Kunihiko Morita, Hideki Muramatsu, Yoshiyuki Takahashi
Publikováno v:
Cell Transplantation, Vol 31 (2022)
Melphalan is widely used for hematopoietic stem cell transplantation (HSCT) conditioning. However, the relationship between its pharmacokinetic (PK) and transplantation outcomes in children has not been thoroughly investigated. We prospectively analy
Externí odkaz:
https://doaj.org/article/11f12047674e4407a8ea450a3451f712
Autor:
Koji Kato, Ryo Maemura, Manabu Wakamatsu, Ayako Yamamori, Motoharu Hamada, Shinsuke Kataoka, Atsushi Narita, Shunsuke Miwata, Yuko Sekiya, Nozomu Kawashima, Kyogo Suzuki, Kotaro Narita, Sayoko Doisaki, Hideki Muramatsu, Hirotoshi Sakaguchi, Kimikazu Matsumoto, Yuka Koike, Osamu Onodera, Makiko Kaga, Nobuyuki Shimozawa, Nao Yoshida
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 18, Iss , Pp 1-6 (2019)
Objective: The prognosis of adrenoleukodystrophy (ALD)with neurological involvement is generally dismal; however, allogeneic stem cell transplantation (SCT) is recognized as effective to stabilize or improve the clinical symptoms of ALD. Herein, we r
Externí odkaz:
https://doaj.org/article/2bec548df4fc4e8fbd0c4373239d7c0b
Autor:
Naruhiko Murase, Kenitiro Kaneko, Asahito Hama, Nao Yoshida, Hirotoshi Sakaguchi, Kosuke Chiba, Makoto Oshiro
Publikováno v:
Journal of Pediatric Surgery Case Reports, Vol 52, Iss , Pp - (2020)
There is currently no consensus regarding the treatment strategy for malignant tumors with trisomy 18 because of the high mortality rate of this genetic disorder. In this study, we reported five cases of hepatoblastoma associated with trisomy 18. Wit
Externí odkaz:
https://doaj.org/article/c282d3962f31436faf20ec02705ec62f
Autor:
Koji Kawaguchi, Katsutsugu Umeda, Satoshi Miyamoto, Nao Yoshida, Hiromasa Yabe, Takashi Koike, Michiko Kajiwara, Hiroshi Kawaguchi, Yoshiyuki Takahashi, Masataka Ishimura, Hirotoshi Sakaguchi, Asahito Hama, Yuko Cho, Maho Sato, Keisuke Kato, Atsushi Sato, Koji Kato, Ken Tabuchi, Yoshiko Atsuta, Kohsuke Imai
Publikováno v:
Bone Marrow Transplantation. 58:600-602
Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis
Autor:
Yoshihiro Inamoto, Wataru Takeda, Tsuneaki Hirakawa, Hirotoshi Sakaguchi, Nobuaki Nakano, Naoyuki Uchida, Noriko Doki, Kazuhiro Ikegame, Yuta Katayama, Masashi Sawa, Takuro Kuriyama, Nobuhiro Hiramoto, Shuichi Ota, Yukiyasu Ozawa, Keisuke Kataoka, Yoshinobu Kanda, Moeko Hino, Takafumi Kimura, Yoshiko Atsuta, Takahiro Fukuda, Koji Nagafuji
Publikováno v:
American Journal of Hematology. 97:1568-1579
We analyzed a Japanese registry database to elucidate the incidence, risk factors, and outcomes of adenovirus (AdV) disease after autologous and allogeneic hematopoietic cell transplantation (HCT) in contemporary real-world patients. We evaluated the
Autor:
Yuichi Kodama, Atsushi Sato, Keisuke Kato, Hirotoshi Sakaguchi, Motohiro Kato, Hirohide Kawasaki, Hidefumi Hiramatsu, Itaru Kato, Takashi Taga, Hiroyuki Shimada
Publikováno v:
International Journal of Hematology. 116:131-138
Ponatinib is effective in adults with Philadelphia chromosome-positive (Ph+) leukemia, resistant or intolerant to second-generation tyrosine kinase inhibitors, but there are limited data on its use in children. The clinical courses of nine pediatric